Skip to main content
. Author manuscript; available in PMC: 2019 May 10.
Published in final edited form as: Eur J Med Chem. 2018 Apr 12;151:777–796. doi: 10.1016/j.ejmech.2018.04.024

Figure 3.

Figure 3

Representative gels for the testing of compounds against Rec TDP2 (A) and TDP1 (B). The compounds were tested at concentrations increasing from 0.51 to 111 μM (for eight doses) or 0.46 to 111 μM (for six doses). The deazafavin SV-163 was tested as the positive control for TDP2 assay at concentrations increasing from 0.017 to 37 μM. The indenoisoquinoline AM-8-3 was tested as the positive control for TDP1 assay at concentrations increasing from 0.051 to 111 μM.